Zobrazeno 1 - 10
of 2 110
pro vyhledávání: ''
Autor:
Nirav S, Kapadia, Gabriel A, Brooks, Mary Beth, Landrum, Lauren, Riedel, Pang-Hsiang, Liu, Andrea, Hassol, Amanda S, Tripp, Shalini, Jhatakia, Colleen M, Kummet, Nancy L, Keating
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 114:39-46
Radiation utilization for breast cancer and metastatic bone disease varies in modality, fractionation, and cost, despite evidence demonstrating equal effectiveness and consensus recommendations such as Choosing Wisely that advocate for higher value c
Publikováno v:
Breast Disease. 41:273-278
BACKGROUND: Mondor disease is superficial thrombophlebitis of the thoracoabdominal wall, mid-upper arm, and penis. Although it is usually a benign disease requiring no specific treatment, little is known about this disease owing to its rarity. OBJECT
Autor:
Reshma, Jagsi, Kent A, Griffith, Frank, Vicini, Thomas, Boike, Michael, Dominello, Gregory, Gustafson, James A, Hayman, Jean M, Moran, Jeffrey D, Radawski, Eleanor, Walker, Lori, Pierce, Vrinda, Narayana
Publikováno v:
JAMA Oncol
IMPORTANCE: Understanding whether physicians accurately detect symptoms in patients with breast cancer is important because recognition of symptoms facilitates supportive care, and clinical trials often rely on physician assessments using Common Toxi
Autor:
Azka Ali, Zhigang Xie, Laura Stanko, Edward De Leo, Young-Rock Hong, Jiang Bian, Karen C. Daily
Publikováno v:
Breast Cancer Research and Treatment. 192:491-499
Breast cancer in men (BC-M) is almost exclusively hormone receptor positive. We conducted a large review of the SEER-Medicare linked database to compare endocrine therapy adherence, discontinuation, and survival outcomes of male versus female patient
Autor:
Brittany L, Bychkovsky, Min-Tzu, Lo, Amal, Yussuf, Carrie, Horton, Marcy, Richardson, Holly, LaDuca, Judy E, Garber, Huma Q, Rana
Publikováno v:
Cancer. 128:1275-1283
Multiple primary cancers (MPCs) are a hallmark of cancer predisposition syndromes. Here the frequency of germline pathogenic variants (PVs) among patients with MPCs is reported.Patients with MPCs who underwent multigene panel testing from March 2012
Publikováno v:
Future Oncology
Introduction: Since breast imaging requires very close contact with patients, a protocol is needed to perform safe daily screening activities during the COVID-19 pandemic. Materials and methods: Patients were triaged and separated into three differen
Autor:
Elizabeth Pan, Tyler J. Nelson, Juan Javier-Desloges, Rana R. McKay, Jesse Nodora, Sandip Pravin Patel, J Kellogg Parsons, Maria Elena Martinez, James D. Murphy, Ithaar Derweesh, Christopher J. Kane, A. Karim Kader, Brent S. Rose
Publikováno v:
Cancer. 128:770-777
BACKGROUND This study was done to determine the representation of minorities, women, and the elderly in National Cancer Institute (NCI) clinical trials. METHODS This is an analysis in the NCI Clinical Data Update System. Patients were evaluated in br
Autor:
A Arencibia-Domínguez, Catalina Falo, Miguel Gil-Gil, N Manent-Molina, S Salinas-Huertas, G Campos, S Vázquez-Gallego, Hector Perez-Montero, Amparo Garcia-Tejedor, M Ortí-Asencio, M Campos-Delgado, F Tormo-Collado, A Guma, A Mestre-Jane, M Beranuy-Rodriguez, M.L. Catasús-Clavé, A Benítez-Segura, Sonia Pernas, A Luzardo-González, J Terra, M Gomila-Sancho, E Martinez-Perez, R Planas-Balagué, María Jesús Pla, J Ponce-Sebastià, B Gonzalez-Pineda, Y Valverde-Alcántara, Ana Belén Trelles Rodríguez, María E. Fernández-Montolí, M Jaraba-Armas, I Campos-Varela
Publikováno v:
Breast Disease. 41:97-108
INTRODUCTION: The Objective was to investigate the incidence of lymphedema after breast cancer treatment and to analyze the risk factors involved in a tertiary level hospital. METHODS: Prospective longitudinal observational study over 3 years post-br
Publikováno v:
JCO Precis Oncol
PURPOSE National Comprehensive Cancer Network guidelines for germline genetic testing have included pancreatic cancer in the context of additional family cancer history for many years but this was not recommended for patients with pancreatic ductal a
Autor:
Nancy Chan, Jiuping Ji, Antoinette R. Tan, Janice M. Mehnert, Alice P. Chen, Jan H. Beumer, Mansi Shah, Joseph Aisner, Murugesan Gounder, Jyoti Malhotra, Rebecca A. Moss, Yong Lin, Brian F. Kiesel, Hongxia Lin, Mark N. Stein, Michael P. Kane
Publikováno v:
Cancer Chemother Pharmacol
Purpose Veliparib (V), an oral poly(ADP-ribose) polymerase (PARP) inhibitor, potentiates effects of alkylating agents and topoisomerase inhibitors in preclinical tumor models. We conducted a phase I trial of V with iv cyclophosphamide (C) and V plus